Achilles Therapeutics Announces Nasdaq Delisting and Liquidation Plans for March 2025
Achilles Therapeutics (NASDAQ: ACHL) has announced its intention to voluntarily delist its American Depositary Shares (ADSs) from Nasdaq and deregister from the SEC. The company has scheduled a General Meeting for March 20, 2025 to obtain shareholder approval for commencing a members’ voluntary liquidation. The company plans to file Form 25 with…